Genomma Lab Internacional SAB de CV (Genomma Lab) develops, sells, and markets pharmaceutical and personal care products. Genomma Lab operates its business in more than 18 countries with over 60 brands in more than 650,000 points of sale. The company's products include over-the-counter (OTC) medicines and personal care products and infant nutrition. In 2025, the OTC Development division launched 17 products across four strategic categories, including Nasalub Max Baby, Maev Medic, Tukol Forte, Balsamo Bengue jar, Lomecan intimate soaps, Next FWD, Alliviax throat, Genobiotics, Silka spray defense, and Silka powder defense. In the personal care division, Genomma Lab launched products such as Tio Nacho Henna, Cicatricure Neuro-Zen, Groomen 500, and Teatrical Piel Coreana. The company also introduced new flavors and formats in its isotonic beverages line, such as Suerox with flavors like lemonade, coconut, grape, and passion fruit.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Genomma Lab Internacional SAB de CV (Genomma Lab) focuses on innovation to strengthen key categories and launch new products. The company emphasizes technology transfer, optimizing third-party contract manufacturing, and acquiring or developing technical dossiers backed by validated scientific support. Product innovations have significantly contributed to the company's sales, with a notable impact on Over-The-Counter and Personal Care sales. The San Cayetano Industrial Complex in the State of Mexico is a centralized facility that handles the transition of innovation project transfers to internal production lines. It includes specialized manufacturing units for over-the-counter (OTC) medicines, personal care products, and isotonic beverages, as well as a regional distribution center. This facility plays a crucial role in managing the company's R&D activities. In FY2025, the OTC division launched 17 products/reformulations and submitted 21 regulatory dossiers for future international market expansion, and the company had four products undergoing bioequivalence studies, and 75 submitted dossiers.